ALTARGO

This brand name is authorized in Brazil, Estonia, Lithuania.

Active ingredients

The drug ALTARGO contains one active pharmaceutical ingredient (API):

1	Retapamulin UNII 4MG6O8991R - RETAPAMULIN
	Retapamulin is a semi-synthetic derivative of the compound pleuromutilin, which is isolated through fermentation from Clitopilus passeckerianus. Retapamulin selectively inhibits bacterial protein synthesis by interacting at a unique site on the 50S subunit of the bacterial ribosome that is distinct from the binding sites of other non-pleuromutilin antibacterial agents that interact with the ribosome.
	Read more about Retapamulin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ALTARGO Ointment	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D06AX13	Retapamulin	D Dermatologicals → D06 Antibiotics and chemotherapeutics for dermatological use → D06A Antibiotics for topical use → D06AX Other antibiotics for topical use
Discover more medicines within D06AX13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	510611201169211
EE	Ravimiamet	1299506, 1299517, 1299528, 1299539
LT	Valstybinė vaistų kontrolės tarnyba	1027224, 1027225, 1027226, 1027227